Log in
Bulk-forming laxative

Psyllium

Psyllium is a soluble fiber derived from Plantago ovata seeds, classified as a bulk-forming laxative. It is primarily used to treat constipation and irritable bowel syndrome, and also lowers LDL cholesterol. The most testable fact is that psyllium must be taken with adequate water to prevent esophageal or bowel obstruction.

Drug classBulk-forming laxative, soluble dietary fiber
MechanismAbsorbs water, increases stool bulk and moisture
Main usesConstipation, IBS, hypercholesterolemia, glycemic control
Key adverse effectEsophageal or intestinal obstruction if inadequate fluid
5 min readFor medical studentsUpdated 2026-10-14

Mechanism of action

Psyllium is a hydrophilic mucilloid derived from the seed husks of Plantago ovata. When ingested with water, psyllium absorbs fluid in the gastrointestinal tract and swells to form a viscous gel. This gel increases fecal bulk and moisture content, which stimulates peristalsis and facilitates bowel movements.

Unlike stimulant laxatives, psyllium does not directly irritate the colonic mucosa or stimulate enteric nerves. Its mechanism is purely mechanical: increased stool volume triggers stretch receptors in the rectal wall, promoting the defecation reflex. The soluble fiber also slows gastric emptying and carbohydrate absorption, contributing to modest reductions in postprandial glucose and serum LDL cholesterol.

Psyllium binds bile acids in the intestinal lumen, interrupting enterohepatic circulation. Hepatic conversion of cholesterol to bile acids increases, lowering circulating LDL cholesterol by 5-10% with regular use. This cholesterol-lowering effect is independent of its laxative action.

High-yield for exams
  • Psyllium must be taken with at least 240 mL of water to prevent esophageal or bowel obstruction.
  • Psyllium is a bulk-forming laxative that works by absorbing water and increasing stool bulk; it does not stimulate the colon.
  • Onset of action is 12-72 hours; it is not appropriate for acute constipation relief.
  • Psyllium lowers LDL cholesterol by 5-10% by binding bile acids and interrupting enterohepatic circulation.
  • Separate psyllium from other oral medications by at least 2 hours to avoid reduced drug absorption.
  • Psyllium is safe in pregnancy (Category B) and is the preferred laxative during gestation.
  • Paradoxical constipation or fecal impaction can occur if psyllium is taken without adequate fluid.
  • Rare but serious: allergic reactions including anaphylaxis, especially in sensitized healthcare workers.

Indications

Psyllium is indicated for:

  • Chronic constipation: First-line bulk-forming agent for functional constipation, particularly in elderly patients and those requiring long-term therapy.
  • Irritable bowel syndrome (IBS): Especially IBS with constipation (IBS-C); soluble fiber improves stool consistency and reduces abdominal discomfort.
  • Hypercholesterolemia: Adjunct to dietary modification and statins for modest LDL reduction.
  • Type 2 diabetes mellitus: Improves glycemic control by slowing carbohydrate absorption.
  • Hemorrhoids and anal fissures: Softens stool and reduces straining.
  • Diverticular disease: Maintains stool bulk and may prevent recurrent diverticulitis (though evidence is mixed).

Psyllium is considered safe for long-term use and does not cause tolerance or dependence, unlike stimulant laxatives.

Pharmacokinetics

Psyllium is not absorbed systemically. It remains in the gastrointestinal lumen throughout its transit. After oral ingestion, psyllium hydrates in the stomach and small intestine, forming a gel matrix. This gel passes through the small bowel and colon, where colonic bacteria partially ferment the soluble fiber into short-chain fatty acids (acetate, propionate, butyrate).

The laxative effect typically begins within 12-72 hours, depending on baseline colonic transit time and hydration status. Psyllium does not undergo hepatic metabolism and is not renally excreted. There are no significant pharmacokinetic interactions, though psyllium can physically bind other drugs in the gut lumen, reducing their absorption.

Adequate fluid intake (at least 240 mL per dose) is essential for proper hydration and gel formation. Insufficient fluid can cause the dry powder to swell prematurely in the esophagus or form a viscous bolus that obstructs the bowel.

Adverse effects

Psyllium is generally well tolerated. Common and serious adverse effects include:

Common

  • Bloating and flatulence: Result from colonic bacterial fermentation; usually transient.
  • Abdominal cramping: Typically mild; resolves with continued use.
  • Nausea: Rare; may occur if taken without adequate water.

Serious

  • Esophageal or bowel obstruction: The most serious risk, especially in patients with esophageal stricture, dysphagia, or pre-existing bowel narrowing. Always take with at least 240 mL of water.
  • Allergic reactions: Rare but documented; includes urticaria, rhinitis, bronchospasm, and anaphylaxis. Occupational exposure (pharmaceutical workers, nurses) increases sensitization risk.
  • Hypokalemia: Theoretical risk with excessive use and chronic diarrhea, though uncommon.

Exam Pearl

Psyllium can cause paradoxical constipation or fecal impaction if taken without sufficient fluid. This is a high-yield board question scenario: patient takes psyllium powder without water and develops severe constipation or obstruction.

Contraindications and warnings

Absolute contraindications:

  • Bowel obstruction or suspicion of obstruction
  • Fecal impaction
  • Acute abdomen
  • Difficulty swallowing (dysphagia)
  • Esophageal stricture or anatomical narrowing

Relative contraindications and warnings:

  • Inflammatory bowel disease (IBD): Use with caution during active flares; bulking agents may worsen symptoms in some patients.
  • Colonic stricture or adhesions: Increased risk of obstruction.
  • Phenylketonuria (PKU): Some psyllium formulations contain aspartame; check product labeling.
  • Allergy history: Patients with plant or pollen allergies may be at higher risk for psyllium hypersensitivity.

Pregnancy and lactation: Psyllium is Pregnancy Category B (FDA legacy classification) and considered safe. It is not absorbed systemically and does not cross the placenta or enter breast milk. It is the preferred laxative during pregnancy.

Drug interactions

Psyllium does not undergo enzymatic metabolism and has no cytochrome P450 interactions. However, it can physically bind drugs in the gastrointestinal tract, reducing their absorption:

  • Warfarin: Psyllium may decrease warfarin absorption; separate administration by at least 2 hours.
  • Digoxin: Reduced bioavailability; monitor digoxin levels and separate dosing.
  • Lithium: Decreased absorption; separate administration.
  • Carbamazepine: Case reports of reduced carbamazepine levels; monitor.
  • Levothyroxine: May bind thyroid hormone; separate by at least 4 hours.
  • Oral hypoglycemics and insulin: Psyllium slows carbohydrate absorption, potentially reducing postprandial glucose spikes. Monitor blood glucose, especially during initiation.

General rule: Administer psyllium at least 2 hours before or after other oral medications to minimize binding interactions. Water-soluble vitamins and minerals (iron, calcium, zinc) may also be bound; consider supplementation timing.

Clinical pearls

  • Start low, go slow: Initiate with a low dose (e.g., 3-5 g once daily) and gradually increase to minimize bloating and gas. Full therapeutic effect may take several days.
  • Hydration is key: Always emphasize adequate fluid intake. The classic board scenario is a patient who takes psyllium without water and develops esophageal or bowel obstruction.
  • Preferred in elderly and pregnant patients: Psyllium does not cause electrolyte disturbances or tolerance, making it safer than stimulant laxatives for long-term use.
  • Cholesterol-lowering dose: Requires 10-12 g/day in divided doses for meaningful LDL reduction; effect is modest (5-10% decrease).
  • IBS evidence: Soluble fiber (psyllium) improves global IBS symptoms better than insoluble fiber (wheat bran), which may worsen bloating.
  • Not for acute relief: Onset of action is 12-72 hours. For acute constipation, consider osmotic laxatives (polyethylene glycol) or stimulants (senna, bisacodyl) instead.
  • Check for aspartame: Some sugar-free formulations contain aspartame; avoid in phenylketonuria.
  • Occupational allergy: Healthcare workers with repeated exposure to psyllium powder are at increased risk for sensitization and IgE-mediated hypersensitivity.

Practice questions

1. A 68-year-old woman with chronic constipation is started on psyllium. Two days later, she presents to the emergency department with severe retrosternal chest pain and dysphagia. Esophagogastroduodenoscopy reveals a large bolus of viscous material obstructing the mid-esophagus. Which of the following is the most likely cause of this presentation?

Answer: B. This patient has esophageal obstruction from psyllium taken without adequate water. Psyllium is a hydrophilic fiber that swells when exposed to moisture; if taken with insufficient fluid, it can form a gel bolus in the esophagus before reaching the stomach. This is a classic complication emphasized on boards. Allergic reactions present with urticaria or bronchospasm, not obstruction. PPIs and reflux do not cause acute obstruction.

2. A 45-year-old man with hypercholesterolemia is started on psyllium 10 grams twice daily in addition to atorvastatin. Four weeks later, his LDL cholesterol decreases by 8%. By which mechanism does psyllium lower LDL cholesterol?

Answer: C. Psyllium lowers LDL cholesterol by binding bile acids in the intestinal lumen, which interrupts enterohepatic circulation. The liver compensates by converting more cholesterol into bile acids, reducing circulating LDL by 5-10%. HMG-CoA reductase inhibition is the mechanism of statins. Ezetimibe inhibits cholesterol absorption at the brush border. LDL receptor upregulation is also a statin effect, and PCSK9 inhibition is the mechanism of evolocumab and alirocumab.

3. A 32-year-old woman with irritable bowel syndrome with constipation (IBS-C) is started on psyllium 5 grams daily. She takes the medication with a small sip of water at bedtime. Three days later, she reports worsening constipation and increased abdominal discomfort. What is the most appropriate next step?

Answer: C. This patient's worsening constipation is due to inadequate fluid intake with psyllium. Without sufficient water, psyllium cannot hydrate properly and may paradoxically worsen constipation or cause impaction. The correct step is to counsel adequate hydration (at least 240 mL per dose). Increasing the dose without fixing hydration will worsen the problem. Insoluble fiber like wheat bran is less effective and may worsen IBS bloating. Discontinuing psyllium or adding a prokinetic is premature.

Frequently asked questions

How does psyllium work?

Psyllium is a soluble fiber that absorbs water in the gastrointestinal tract and swells to form a gel. This increases fecal bulk and moisture, which stimulates peristalsis and facilitates bowel movements. Unlike stimulant laxatives, psyllium does not irritate the colon; its mechanism is purely mechanical. It also binds bile acids, leading to modest LDL cholesterol reduction.

What are the side effects of psyllium?

Common side effects include bloating, flatulence, and mild abdominal cramping, which usually resolve with continued use. The most serious risk is esophageal or bowel obstruction, which occurs if psyllium is taken without adequate water. Rare allergic reactions, including urticaria, bronchospasm, and anaphylaxis, have been reported. Always take psyllium with at least 240 mL of fluid.

Is psyllium safe during pregnancy?

Yes, psyllium is considered safe during pregnancy and is classified as Pregnancy Category B. It is not absorbed systemically, does not cross the placenta, and does not enter breast milk. Psyllium is the preferred laxative for pregnant women with constipation because it does not cause electrolyte disturbances or uterine stimulation, unlike stimulant laxatives such as senna or bisacodyl.

Can psyllium interact with other medications?

Psyllium can physically bind medications in the gastrointestinal tract, reducing their absorption. Drugs affected include warfarin, digoxin, lithium, levothyroxine, and carbamazepine. To minimize interactions, take psyllium at least 2 hours before or after other oral medications. Psyllium does not undergo hepatic metabolism and has no cytochrome P450 interactions. Monitor drug levels as needed.

Psyllium vs polyethylene glycol — what is the difference?

Psyllium is a bulk-forming laxative that increases stool bulk by absorbing water, while polyethylene glycol (PEG) is an osmotic laxative that draws water into the colon. PEG has a faster onset (24-48 hours vs 12-72 hours) and is better for acute constipation. Psyllium is preferred for chronic management and has the added benefit of lowering LDL cholesterol. Both are safe for long-term use and do not cause dependency.

Conditions it is used for

ConstipationIrritable bowel syndromeHypercholesterolemiaType 2 diabetes mellitusHemorrhoidsAnal fissureDiverticular disease
MethylcellulosePolycarbophilPolyethylene glycolLactuloseSennaBisacodylDocusateLinaclotide

Sources and further reading

DailyMed (FDA labels)StatPearls (NCBI Bookshelf)MedlinePlusWHO ATC/DDD index: A06AC01

Educational content for medical students, prepared by the WhiteCoat Pro editorial team with AI assistance; every page is reviewed by a second AI model for factual errors. It is not medical advice and does not replace the product label, local guidelines or a clinician.